Stocks News

LAST PRICE
303.4900
TODAY'S CHANGE (%)
Trending Up14.9100 (5.1667%)

Bid / Lots
295.5500/ 1
Ask / Lots
322.5100/ 1
Open / Previous Close
290.2500 / 288.5800
Day Range
Low 288.8000
High 308.4300
52 Week Range
Low 168.2462
High 368.2900
Volume
467,873
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 6, 2024
- Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences, from 8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
  8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: MDGL
  
  Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences
  
  CONSHOHOCKEN, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in fireside chats at three upcoming investor conferences:
- Madrigal Pharmaceuticals Insider Sold Shares Worth $1,504,703, According to a Recent SEC Filing, from 3:28AM ET on Wednesday Nov 06, 2024 by MT Newswires
  3:28AM ET on Wednesday Nov 06, 2024 by MT Newswires
  Companies Mentioned: MDGL
  03:28 AM EST, 11/06/2024 (MT Newswires) -- Richard S Levy, Director, on November 01, 2024, sold 5,000 shares in Madrigal Pharmaceuticals (MDGL) for $1,504,703. Following the Form 4 filing with the SEC, Levy has control over a total of 11,012 shares ...
Nov 5, 2024
- DJ Madrigal Pharmaceuticals Is Maintained at Neutral by B. Riley Securities, from 11:22AM ET on Tuesday Nov 05, 2024 by Dow Jones
  11:22AM ET on Tuesday Nov 05, 2024 by Dow Jones
  Companies Mentioned: MDGL
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/MDGL/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 05, 2024 11:22 ET (16:22 GMT)
- B. Riley Adjusts Price Target on Madrigal Pharmaceuticals to $236 From $194, Maintains Neutral Rating, from 9:14AM ET on Tuesday Nov 05, 2024 by MT Newswires
  9:14AM ET on Tuesday Nov 05, 2024 by MT Newswires
  Companies Mentioned: MDGL
  09:14 AM EST, 11/05/2024 (MT Newswires) -- Madrigal Pharmaceuticals (MDGL) has an average outperform rating and price target range of $155 to $530, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic resea...
Nov 1, 2024
- DJ Madrigal Pharmaceuticals Is Maintained at Buy by UBS, from 2:37PM ET on Friday Nov 01, 2024 by Dow Jones
  2:37PM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: MDGL
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/MDGL/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 01, 2024 14:37 ET (18:37 GMT)

Today
- Did Viking Therapeutics, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - VKTX, from 46 minutes ago by Dow Jones
  46 minutes ago by Dow Jones
  Companies Mentioned: VKTX
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX, from 1 hour ago by PR Newswire
  1 hour ago by PR Newswire
  Companies Mentioned: VKTX
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX, from 1 hour ago by Dow Jones
  1 hour ago by Dow Jones
  Companies Mentioned: VKTX
- DJ Cytokinetics Price Target Maintained With a $120.00/Share by HC Wainwright & Co., from 15 hours ago by Dow Jones
  15 hours ago by Dow Jones
  Companies Mentioned: CYTK
- Levi & Korsinsky Reminds Shareholders of an Investigation into Viking Therapeutics, Inc. (VKTX) Regarding Potential Securities Fraud Allegations, from 15 hours ago by Dow Jones
  15 hours ago by Dow Jones
  Companies Mentioned: VKTX
Nov 16, 2024
- ATTENTION VKTX SHAREHOLDERS: Investors who lost money on Viking Therapeutics, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation, from 7:46PM ET on Saturday Nov 16, 2024 by Dow Jones
  7:46PM ET on Saturday Nov 16, 2024 by Dow Jones
  Companies Mentioned: VKTX
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX, from 12:02PM ET on Saturday Nov 16, 2024 by Dow Jones
  12:02PM ET on Saturday Nov 16, 2024 by Dow Jones
  Companies Mentioned: VKTX
- Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024, from 9:00AM ET on Saturday Nov 16, 2024 by Dow Jones
  9:00AM ET on Saturday Nov 16, 2024 by Dow Jones
  Companies Mentioned: CYTK
- Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024, from 9:00AM ET on Saturday Nov 16, 2024 by Dow Jones
  9:00AM ET on Saturday Nov 16, 2024 by Dow Jones
  Companies Mentioned: CYTK
Nov 14, 2024
- Viking Therapeutics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Viking Therapeutics, Inc. (VKTX), from 5:31PM ET on Thursday Nov 14, 2024 by Dow Jones
  5:31PM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: VKTX

Madrigal Pharmaceuticals Inc
NASDAQ:MDGLUnited States

Search Criteria

Nov 6, 2024

Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences, from 8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones

Madrigal Pharmaceuticals Insider Sold Shares Worth $1,504,703, According to a Recent SEC Filing, from 3:28AM ET on Wednesday Nov 06, 2024 by MT Newswires

Nov 5, 2024

DJ Madrigal Pharmaceuticals Is Maintained at Neutral by B. Riley Securities, from 11:22AM ET on Tuesday Nov 05, 2024 by Dow Jones

B. Riley Adjusts Price Target on Madrigal Pharmaceuticals to $236 From $194, Maintains Neutral Rating, from 9:14AM ET on Tuesday Nov 05, 2024 by MT Newswires

Nov 1, 2024

DJ Madrigal Pharmaceuticals Is Maintained at Buy by UBS, from 2:37PM ET on Friday Nov 01, 2024 by Dow Jones

Peers Headlines

Today

Did Viking Therapeutics, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - VKTX, from 46 minutes ago by Dow Jones

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX, from 1 hour ago by PR Newswire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX, from 1 hour ago by Dow Jones

DJ Cytokinetics Price Target Maintained With a $120.00/Share by HC Wainwright & Co., from 15 hours ago by Dow Jones

Levi & Korsinsky Reminds Shareholders of an Investigation into Viking Therapeutics, Inc. (VKTX) Regarding Potential Securities Fraud Allegations, from 15 hours ago by Dow Jones

Nov 16, 2024

ATTENTION VKTX SHAREHOLDERS: Investors who lost money on Viking Therapeutics, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation, from 7:46PM ET on Saturday Nov 16, 2024 by Dow Jones

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX, from 12:02PM ET on Saturday Nov 16, 2024 by Dow Jones

Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024, from 9:00AM ET on Saturday Nov 16, 2024 by Dow Jones

Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024, from 9:00AM ET on Saturday Nov 16, 2024 by Dow Jones

Nov 14, 2024

Viking Therapeutics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Viking Therapeutics, Inc. (VKTX), from 5:31PM ET on Thursday Nov 14, 2024 by Dow Jones